mRNA expression of genes altered by 5-azacytidine treatment in cancer cell lines is associated with clinicopathological parameters of human cancers

Journal of Cancer Research and Clinical Oncology

Volumn 127, Issue 12, 2001, Pages 697-706

  Kanai, Y ^a   Ushijima, S ^a   Saito, Y ^a   Nakanishi, Y ^a   Sakamoto, M ^a   Hirohashi, S ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

5 azacytidine; B4 2 protein; Cofilin; NA methylation; TROP2; Wip1

Indexed keywords

AZACITIDINE; BRCA2 PROTEIN; COFILIN; DNA; HERMES ANTIGEN; INTERFERON INDUCIBLE PROTEIN[6-10]; MESSENGER RNA; PROTEIN B4 2; PROTEIN ROCK; PROTEIN TROP2; PROTEIN WIP1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BIOASSAY; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HEPATITIS B; HEPATITIS B VIRUS; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MULTIPLE CANCER; MUTATION; NUCLEOTIDE SEQUENCE; PORTAL VEIN; PRIORITY JOURNAL; STOMACH CARCINOMA;

EID: 0035167742     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004320100284     Document Type: Article

References (49)

1. Placental alkaline phosphatase-like isoenzymes produced by human gastric cancer cells
2. Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines
3. Cloning a cDNA from human NK/T cells which codes for a protein with high proline content
4. DNA hypomethylation leads to elevated mutation rates
5. The structure and expression of the murine wild type p53-induced phosphatase 1 (Wip1) gene
6. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
7. Generation of an integrated transcription map of the BRCA2 region on chromosome 13q12-q13
8. The classification of cancer of the rectum
9. DNA hypermethylation at the D17S5 locus in non-small cell lung cancers: Its association with smoking history
10. 2-binding sequence in the cytoplasmic domain of TROP-2
11. Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner
12. Cloning of the gene encoding Trop-2, a cellsurface glycoprotein expressed by human carcinomas
13. The 5-methylcytosine content of DNA from human tumors
14. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma
15. INK4B1
16. An essential part for Rho-associated kinase in the transcellular invasion of tumor cells
17. Cancer epigenetics comes of age
18. Toxicity of 5-aza-2'-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation
19. Aberrant DNA methylation on chromosome 16 is an early event in hepatocarcinogenesis
20. The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas
21. DNA hypermethylation at the D17S5 locus is associated with gastric carcinogenesis
22. DNA hypermethylation at the D17S5 locus and reduced HIC-1 mRNA expression are associated with hepatocarcinogenesis
23. Aberrant DNA methylation precedes loss of heterozygosity on chromosome 16 in chronic hepatitis and liver cirrhosis
24. Inhibition of DNA methyltransferase stimulates the expression of signal transducer and activator of transcription 1, 2, and 3 genes in colon tumor cells
25. Methylation profiles of genomic DNA of mouse developmental brain detected by restriction landmark genomic scanning (RLGS) method
26. The President's cancer, the Dukes classification, and confusion
27. A novel serine/threonine kinase binding the Ras-related RhoA GTPase which translocates the kinase to peripheral membranes
28. DNA hypermethylation is associated with 17p allelic loss in neural tumors
29. Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors
30. RNA fingerprinting and differential display using arbitrarily primed PCR
31. 5' CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers
32. Pharmacological approach for optimization of the dose schedule of 5-Aza-2'-deoxycytidine (Decitabine) for the therapy of leukemia
33. Evaluation of an inhibitor of DNA methylation, 5-aza-2'-deoxycytidine, for the treatment of lung cancer and the future role of gene therapy
34. Comparison of seven cell lines derived from human gastric carcinomas
35. Growth-promoting effect of gastrin on human gastric carcinoma cell line TMK-1
36. DNA methylation: Past, present and future directions
37. Actin, cofilin and cognition
38. Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene
39. Early stages of multistep hepatocarcinogenesis: Adenomatous hyperplasia and early hepatocellular carcinoma
40. High frequency mutagenesis by a DNA methyltransferase
41. Isolation of DNA fragments associated with methylated CpG islands in human adenocarcinomas of the lung using a methylated DNA binding column and denaturing gradient gel electrophoresis
42. Clonal origin of atypical adenomatous hyperplasia of the liver and clonal identity with hepatocellular carcinoma
43. Establishment of methylation-sensitive-representational difference analysis and isolation of hypo- and hypermethylated genomic fragments in mouse liver tumors
44. Hypomethylation of CCGG sites in the 3' region of H-ras protooncogene is frequent and is associated with H-ras allele loss in non-small cell lung cancer
45. Down-regulation of CD44 expression in human prostatic carcinoma cell lines is correlated with DNA hypermethylation
46. Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene
47. Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract
48. Clonal growth of hepatitis B virus-integrated hepatocytes in cirrhotic liver nodule
49. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas